Imaging services provider Medical Resources of Hackensack, NJ, got at least a temporary reprieve from NASDAQ for its listing on the stock exchange, the company reported June 2. Medical Resources' NASDAQ listing was in jeopardy due to the company's
Imaging services provider Medical Resources of Hackensack, NJ, got at least a temporary reprieve from NASDAQ for its listing on the stock exchange, the company reported June 2. Medical Resources' NASDAQ listing was in jeopardy due to the company's inability to file its 10-K report with the Securities and Exchange Commission for 1997 financial results. The firm recently filed the report and will be able to maintain its listing, at least for the next several weeks.
NASDAQ set several conditions for the company's continued listing on the exchange. Medical Resources must file its quarterly 10-Q report for its first financial quarter (end-March) by June 12, and by July 24 must meet either NASDAQ's minimum net tangible assets requirement or an alternative requirement that its stock trade at a minimum bid of $5 a share. Medical Resources currently meets neither the tangible assets requirement nor the $5 a share requirement, although the company said it would implement a reverse stock split to meet the latter, if necessary.
FDA Clears Virtually Helium-Free 1.5T MRI System from Siemens Healthineers
June 26th 2025Offering a cost- and resource-saving DryCool magnet technology, the Magnetom Flow.Ace MRI system reportedly requires 0.7 liters of liquid helium for cooling over the lifetime of the device in contrast to over 1,000 liters commonly utilized with conventional MRI platforms.
SNMMI: Botox May Facilitate Relief from Dry Mouth Side Effect of PSMA-Targeted Radiopharmaceuticals
June 25th 2025For patients being treated with radiopharmaceutical agents for metastatic prostate cancer, the combination of botulinum toxin and an anti-nausea patch led to a 30 percent reduction in PSMA uptake in the salivary glands, according to preliminary research findings presented at the SNMMI conference.